Untitled | QuestionPro

In the event that you do treat patients with RBCGF, how likely would you be to recommend XXX? Please respond by indicating 1 through 10 where 1 is unlikely and 10 is very likely.

Please indicate your position

What is your understanding of the changes in Medicare Part B reimbursement that are planned for 2005 in regard to reimbursement of injectable/IV chemotherapy that is administered in the physician's office? Check all that apply

Medicare will use Average Sales Price (ASP) as a basis for reimbursement

Medicare will use Average Wholesale Price (AWP) as a basis for reimbursement

reimbursement for drug charges for most generic products will decrease

reimbursement for drug charges for most generic products will increase

reimbursement for most branded products will decrease

reimbursement for most branded products will increase

reimbursement for drug charges for most branded products will increase

reimbursement for administration/infusion will decrease

reimbursement for administration/infusion will increase

In light of the changes in Medicare Part B reimbursement that went into effect on January 1, 2005, regarding reimbursement for injectable/IV chemotherapies administered in the office, have you or someone else in your practice undertaken any analysis to date to estimate the financial impact on your practice?

Yes

Overall, what impact do you expect the 2005 Medicare Part B reimbursement changes for injectable/IV chemotherapy to have on revenues to your practice? (Check one)

a negative impact - by what percentage do you expect your revenue to decrease? ______%

no meaningful impact/neutral

a positive impact - by what percentage do you expect your revenue to increase?______%

Step 1 of 2

Please contact [email protected] if you have any questions regarding this survey.